The Kenneth Norris Jr. comprehensive Cancer Center at the University of Southern California has been in existence since mid-1971 and continuously supported by a Cancer Center (Core) Support Grant since 1973. In the intervening years, the Center has developed to a major regional resource for cancer research, treatment, prevention and education. Center facilities have been built and developed with support from the NCI, the University, and, in its early days, the County of Los Angeles. Research is organized into six program areas, each headed by two senior investigators: Gene Regulation; Tumor Biology; lmmunobiology, Pathogenesis and Treatment; Developmental Therapeutics; Cancer Etiology; and Cancer Prevention Research and Education. In this application we are requesting the following: 1. partial salary support for the Center's senior leadership who are responsible for planning and overseeing our research efforts; 2. partial salary support for selected staff investigators who qualify according to NCI guidelines; 3. support for planning and evaluation to keep the Center at the forefront of cancer research; 4. support for the administrative infrastructure of the Center; 5. partial support for the Center's shared resources and the development of one new facility; 6. and support for developmental funds to help us recruit new investigators in the areas we have targeted for expansion. Continued funding from the Cancer Center (Core) Support Grant program will allow us build on and expand our strengths and to develop initiatives in promising areas of cancer research, treatment, prevention and education.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014089-18
Application #
3101386
Study Section
Special Emphasis Panel (SRC (V3))
Project Start
1980-04-01
Project End
1995-11-30
Budget Start
1992-12-01
Budget End
1993-11-30
Support Year
18
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of Southern California
Department
Type
Schools of Medicine
DUNS #
041544081
City
Los Angeles
State
CA
Country
United States
Zip Code
90089
Schaal, Justin B; Maretzky, Thorsten; Tran, Dat Q et al. (2018) Macrocyclic ?-defensins suppress tumor necrosis factor-? (TNF-?) shedding by inhibition of TNF-?-converting enzyme. J Biol Chem 293:2725-2734
Iriondo, Oihana; Liu, Yarong; Lee, Grace et al. (2018) TAK1 mediates microenvironment-triggered autocrine signals and promotes triple-negative breast cancer lung metastasis. Nat Commun 9:1994
Robison, Nathan J; Yeo, Kee Kiat; Berliner, Adrian P et al. (2018) Phase I trial of dasatinib, lenalidomide, and temozolomide in children with relapsed or refractory central nervous system tumors. J Neurooncol 138:199-207
Naseem, Madiha; Barzi, Afsaneh; Brezden-Masley, Christine et al. (2018) Outlooks on Epstein-Barr virus associated gastric cancer. Cancer Treat Rev 66:15-22
Sebio, A; Stintzing, S; Heinemann, V et al. (2018) A genetic variant in Rassf1a predicts outcome in mCRC patients treated with cetuximab plus chemotherapy: results from FIRE-3 and JACCRO 05 and 06 trials. Pharmacogenomics J 18:43-48
Peres, Lauren C; Risch, Harvey; Terry, Kathryn L et al. (2018) Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies. Int J Epidemiol 47:460-472
Peddi, Santosh; Pan, Xiaoli; MacKay, John Andrew (2018) Intracellular Delivery of Rapamycin From FKBP Elastin-Like Polypeptides Is Consistent With Macropinocytosis. Front Pharmacol 9:1184
Guo, Hao; Lee, Changrim; Shah, Mihir et al. (2018) A novel elastin-like polypeptide drug carrier for cyclosporine A improves tear flow in a mouse model of Sjögren's syndrome. J Control Release 292:183-195
Zhao, Yi; Wu, Kaijin; Wu, Yongfeng et al. (2018) Characterization of Imatinib Resistant CML Leukemic Stem/Initiating Cells and Their Sensitivity to CBP/Catenin Antagonists. Curr Mol Pharmacol 11:113-121
Kahn, Michael (2018) Wnt Signaling in Stem Cells and Cancer Stem Cells: A Tale of Two Coactivators. Prog Mol Biol Transl Sci 153:209-244

Showing the most recent 10 out of 842 publications